期刊文献+

人乳头状瘤病毒16型E7基因重组腺相关病毒载体的构建及E7 mRNA和蛋白在真核细胞中的表达 被引量:1

Construction of adeno-associated virus vector containing human papilloma virus 16 E7 gene and its expression in eukaryotic cells
原文传递
导出
摘要 目的构建含人乳头状瘤病毒16型E7(HPV16E7)基因的重组腺相关病毒(rAAV)载体,并验证HPV16E7mRNA和蛋白在真核细胞中的表达。方法将含腺相关病毒(AAV)末端反向重复序列及HPV16E7基因的重组质粒pAAVMCSE7、含rep/cap基因的质粒pAAVRC及辅助质粒pAAVhelper共同转染胚胎肾细胞系HEK293细胞,回收、纯化病毒颗粒并鉴定,斑点杂交法测定病毒滴度,RTPCR技术、蛋白印迹法验证HPV16E7mRNA和蛋白在真核细胞中的表达。结果电镜鉴定结果显示真核细胞中有病毒颗粒存在,斑点杂交法测定病毒滴度为1×1011/ml。含HPV16E7基因的rAAV载体转染真核细胞后,在细胞内可检测到HPV16E7mRNA和蛋白的表达。结论本实验成功构建了含HPV16E7基因的rAAV载体,经验证HPV16E7mRNA和蛋白在真核细胞内有表达。 Objective To construct recombinant adeno-associated virus vector containing human papilloma virus (HPV)16E7 gene and identify its effectiveness of expression in eukaryotic cell. Methods(Recombinant adeno-associatedvirus particles containing HPV16E7 gene were generated by co-transfection of plasmids pAAV-MCS-E7, pAAV-RC and pAAV-helper into HEK293 cells. The viral particles were collected and purified. The vector titer was measured by southern blot. After the eukaryotic cells were transfected by virus particles, RT-PCR and western blot analysis were performed to identify rAAV expression. Results(The recombinant) adeno-associated virus vector containing HPV16E7 gene was correctly constructed. The vector titer measured by southern blot was approximately 1×10^(11)/ml. After the eukaryotic cells were transfected by the recombinant adeno-associated virus vector, the expression of HPV16E7 gene was identified by RT-PCR and western blot. Conclusions Recombinant adeno-associated virus HPV16E7 vector is successfully constructed and can stably express in eukaryotic cells.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2005年第7期480-483,共4页 Chinese Journal of Obstetrics and Gynecology
  • 相关文献

参考文献12

  • 1Si JY, Lee K, Han R, et al. A research for the relationship between human papillomavirus and human uterine cervical carcinoma. I. The identification of viral genome and subgenomic sequences in biopsies of Chinese patients.J Cancer Res Clin Oncol, 1991,117:454-459.
  • 2Grimm D, Kleinschmidt JA. Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use.Hum Gene Ther,1999,10:2445-2450.
  • 3Matsushita T, Elliger S, Elliger C, et al. Adeno-associated virus vectors can be efficiently produced without helper virus.Gene Ther,1998,5:938-945.
  • 4李桂林,王任直,王欣,窦万臣,张波,田士强,任祖渊,苏长保.质粒辅助重组腺病毒相关病毒的制备和纯化[J].中华医学杂志,2003,83(14):1255-1258. 被引量:8
  • 5Clark KR, Liu X, McGrath JP,et al. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses.Hum Gene Ther,1999,10:1031-1039.
  • 6Joseph S, David WR. Molecular cloning: a laoratory manual.3rd ed. New York: Cold Spring Harbor Laboratory Press, 2001. 1713-1726.
  • 7Adams M, Navabi H, Jasani B, et al. Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly.Vaccine,2003,21:787-790.
  • 8Liu Y, Chiriva-Internati M, Grizzi F, et al. Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector.Cancer Gene Ther,2001,8:948-957.
  • 9Jolly D. Viral vector systems for gene therapy.Cancer Gene Ther,1994 ,1:51-64.
  • 10王平,彭芝兰,王和,刘珊玲,王中凡.子宫颈鳞癌组织中人乳头状瘤病毒E_7蛋白与Rb基因产物的关系[J].中华妇产科杂志,1997,32(12):722-724. 被引量:4

二级参考文献6

  • 1Xiao X, Li J, Richard Jude Samulski. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper aqdenovirus. J virol, 1998, 72:2224-2232.
  • 2Inoue N, Russel D W. Packing cells based on inducible gene amplification for the production of adeno-associated virus vectors. J Virol, 1998, 72: 7024-7031.
  • 3Conway JE, Zolotukhin S, Muzyczka N, et al. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap. J Virol, 1997, 71: 8780-8789.
  • 4Zolozukhin S, Byrne BJ, Mason E, et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Therapy, 1999, 6: 973-985.
  • 5Clark KR, Liu X, McGrath JP, et al. Higly purified rocombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Human Gene Therapy,1999, 10: 1031-1039.
  • 6吴小兵,董小岩,伍志坚,屈建国,侯云德.一种快速高效分离和纯化重组腺病毒伴随病毒载体的方法[J].科学通报,2000,45(19):2071-2075. 被引量:75

共引文献10

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部